2004 WHO classification of the renal tumors of the adults A Lopez-Beltran, M Scarpelli, R Montironi, Z Kirkali European urology 49 (5), 798-805, 2006 | 1144 | 2006 |
Metabolic phenotype of bladder cancer F Massari, C Ciccarese, M Santoni, R Iacovelli, R Mazzucchelli, F Piva, ... Cancer treatment reviews 45, 46-57, 2016 | 243 | 2016 |
Immune checkpoint inhibitors for the treatment of bladder cancer A Lopez-Beltran, A Cimadamore, A Blanca, F Massari, N Vau, M Scarpelli, ... Cancers 13 (1), 131, 2021 | 205 | 2021 |
2009 update on the classification of renal epithelial tumors in adults A Lopez‐Beltran, JC Carrasco, L Cheng, M Scarpelli, Z Kirkali, ... International Journal of Urology 16 (5), 432-443, 2009 | 204 | 2009 |
Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology … R Montironi, R Mazzuccheli, M Scarpelli, A Lopez‐Beltran, G Fellegara, ... BJU international 95 (8), 1146-1152, 2005 | 178 | 2005 |
Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate R Montironi, R Mazzucchelli, A Lopez-Beltran, L Cheng, M Scarpelli Nature Clinical Practice Urology 4 (6), 321-332, 2007 | 157 | 2007 |
Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications G Aurilio, A Cimadamore, R Mazzucchelli, A Lopez-Beltran, E Verri, ... Cells 9 (12), 2653, 2020 | 153 | 2020 |
Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? SS Shen, LD Truong, M Scarpelli, A Lopez-Beltran Archives of Pathology & Laboratory Medicine 136 (4), 410-417, 2012 | 148 | 2012 |
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment B Marconi, I Bobyr, A Campanati, E Molinelli, V Consales, V Brisigotti, ... Intractable & rare diseases research 4 (3), 113-122, 2015 | 130 | 2015 |
Neuroendocrine tumours of the urinary system and male genital organs: clinical significance R Mazzucchelli, D Morichetti, A Lopez‐Beltran, L Cheng, M Scarpelli, ... BJU international 103 (11), 1464-1470, 2009 | 127 | 2009 |
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas M Scarpelli, U Salvolini, L Diamanti, R Montironi, L Chiaromoni, ... Neuroradiology 36, 393-398, 1994 | 109 | 1994 |
PD-L1 assessment in urothelial carcinoma: a practical approach M Eckstein, A Cimadamore, A Hartmann, A Lopez-Beltran, L Cheng, ... Annals of Translational Medicine 7 (22), 2019 | 106 | 2019 |
Rare and unusual histological variants of prostatic carcinoma: clinical significance R Mazzucchelli, A Lopez‐Beltran, L Cheng, M Scarpelli, Z Kirkali, ... BJU international 102 (10), 1369-1374, 2008 | 106 | 2008 |
Epithelial to mesenchymal transition in renal cell carcinoma: implications for cancer therapy F Piva, M Giulietti, M Santoni, G Occhipinti, M Scarpelli, A Lopez-Beltran, ... Molecular diagnosis & therapy 20, 111-117, 2016 | 103 | 2016 |
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies F Piva, M Santoni, MR Matrana, S Satti, M Giulietti, G Occhipinti, F Massari, ... Expert review of molecular diagnostics 15 (9), 1201-1210, 2015 | 103 | 2015 |
Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? R Montironi, R Mazzucchelli, A Lopez-Beltran, G Martignoni, L Cheng, ... European urology 54 (6), 1237-1246, 2008 | 103 | 2008 |
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer A Lopez-Beltran, RJ Luque, R Mazzucchelli, M Scarpelli, R Montironi Journal of clinical pathology 55 (9), 641-647, 2002 | 101 | 2002 |
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives M Santoni, A Conti, L Burattini, R Berardi, M Scarpelli, L Cheng, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 630-637, 2014 | 93 | 2014 |
Pathology and genetics: tumours of the urinary system and male genital system: clinical implications of the 4th Edition of the WHO classification and beyond. R Montironi, L Cheng, M Scarpelli, A Lopez-Beltran European urology 70 (1), 120-123, 2016 | 92 | 2016 |
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy R Giampieri, E Maccaroni, A Mandolesi, M Del Prete, K Andrikou, ... Gastric Cancer 20, 156-163, 2017 | 90 | 2017 |